10/05/2023
Virtual Crossmatching and Epitope Analysis As Informational Aids in the Transplant Decision Making Process: A…
11/16/2022
The Proof is in the Metrics – AlloSeq HCT Case Studies
11/07/2022
Comprehensive HCT Software Quality Metrics – Advanced Training
10/19/2022
Streamlined Detection of Chimerism Using NGS – Advances of AlloSeq HCT Assay
08/22/2022
Tackling Health Equity in Organ Transplantation
07/20/2022
Merge Ahead: The New OPO Landscape & Ways Your OPO Can Prepare
06/29/2022
Regional Webinar Series: Surveillance of dd-cDNA by Next Generation Sequencing – AlloSeq cDNA Practical…
03/29/2022
AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
03/02/2022
Score 6 Advanced Options and Troubleshooting Tips – Fast Results with Automated Analysis
01/26/2022
Transplant Quality Outcomes – Part 2: Leveraging New & Existing Tools to Manage Your Quality Outcomes:…
01/19/2022
Managing Your Outcomes in a World of Imperfect Organs and Higher Risk Recipients
01/19/2022
Optimizing For The Long-Term Success Of Transplant Patients
12/09/2021
Making Waitlist Management More Efficient Part 2
12/01/2021
Improving your CareDx Surveillance Testing Workflows
11/30/2021
Making Waitlist Management More Efficient – Part 1
11/16/2021
Surviving and Thriving in the New Organ Allocation Systems – Part 2
11/11/2021
Improving your CareDx Surveillance Testing Workflows
11/09/2021
Surviving and Thriving in the New Organ Allocation Systems – Part 1
09/24/2021
Role of Inflammation and Injury Post Heart Transplantation
08/29/2021
ESOT 2021 – Symposium – Changing the Transplant Care Paradigm Advanced Strategies for Allograft…
08/18/2021
2021 HLA Webinar Series #6: Revolutionizing Engraftment Monitoring – AlloSeq HCT – The Latest Innovation…
08/10/2021
AlloSeq cfDNA Webinar 2021, English + Portuguese–Organ Transplant Surveillance with AlloSeq cfDNA
06/30/2021
2021 ESOT Webinar
06/30/2021
ADN libre de células derivado de donante (dd-cfDNA): Vigilancia personalizada no invasiva en postrasplante